HoxB7 Antibodies

Santa Cruz Biotechnology offers a broad range of HoxB7 monoclonal antibodies for advanced research in developmental biology and gene regulation. HoxB7 monoclonal antibodies are compatible with multiple techniques, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). HoxB7, a member of the homeobox gene family, plays a critical role in the regulation of embryonic development and the maintenance of body plan organization. HoxB7 is involved in processes such as cell differentiation and organogenesis, making it essential for understanding developmental pathways and potential implications in cancer biology. The study of HoxB7 has revealed significant insights into the mechanisms underlying various developmental disorders and malignancies. Researchers worldwide rely on HoxB7 monoclonal antibodies to investigate gene expression patterns during embryonic development. Understanding HoxB7 function has opened new avenues for exploring therapeutic approaches in developmental disorders. Current research utilizing HoxB7 monoclonal antibodies continues to uncover novel regulatory mechanisms in both normal development and disease states. Santa Cruz Biotechnology monoclonal antibodies enable researchers to advance scientific knowledge and contribute to breakthrough discoveries in developmental biology and cancer research.